LCM
ANRO icon

Landscape Capital Management’s Alto Neuroscience ANRO Stock Holding History

Landscape Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,083
Closed -$407K – 944
2026
Q1 		$407K Buy
+18,083
New +$335K 0.03% 535

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Landscape Capital Management's ANRO Position: Q2 2026 in Review

Landscape Capital Management sold out of Alto Neuroscience (ANRO) in Q2 2026, closing a stake of 18,083 shares — an estimated $407K sold.

Landscape Capital Management first reported a position in ANRO in Q1 2026 and held it in 1 quarter. The position peaked at $407K in Q1 2026. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Landscape Capital Management reported no remaining Alto Neuroscience position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 18,083 Alto Neuroscience shares in Q2 2026, an estimated $407K.
  • Landscape Capital Management first reported a position in Alto Neuroscience in Q1 2026 and held it in 1 quarter.
  • Landscape Capital Management's Alto Neuroscience position peaked at $407K in Q1 2026.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.